Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fa...
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biophar...
“We can all take steps to help prevent Alzheimer’s disease or slow its course,” says Dr. Mohamme...
Phoenix Life Sciences International Limited, an international adaptive healthcare solutions company has announced that M...
The Board of Directors of Prometic Life Sciences Inc. has announced that it has named Prof. Simon Best as Interim Chief ...
Biotech Start-up company, Relay Therapeutics has announced the successful completion of a $400 million Series C financin...
POLYTECH sold the three millionth implant since its establishment in 1986. The company is the only German manufacturer a...
Merck, a leading science and technology company, has evolved its agreement with Intrexon Corporation for the development...
The preclinical findings published in Cell Reports reveal that activation of a specific transcription factor induces a p...
Gilead Sciences and Scholar Rock Holding Corporation have announced that the companies have entered into a strategi...
Pharma major, Bayer has recently received the European Commission approval for its hemophilia A long-acting injectable m...
Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapie...
Singapore - Smith & Nephew announces that it has agreed to acquire Ceterix Orthopaedics and its Novo...
Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have...
Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million ...
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...
DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican ph...
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel t...
